Health & Biotech
Stories by Tim Boreham
Health & Biotech
Dr Boreham’s Crucible: the story of Clinuvel, an Australian triumph
Health & Biotech
The Health Kick Podcast with Tim Boreham: Anatara Lifesciences
Health & Biotech
Dr Boreham’s Crucible: Recce Pharmaceuticals, the emerging superbug killer
Health & Biotech
The Health Kick Podcast with Tim Boreham: Kazia Therapeutics
Health & Biotech
Dr Boreham’s Crucible: Actinogen on the mend after a near-death experience
Health & Biotech
The Health Kick Podcast with Tim Boreham: BioScience Managers
Health & Biotech
Dr Boreham’s Crucible: Suda shows far more promise than its ‘penny-dreadful’ status suggests
Health & Biotech
The Health Kick Podcast with Tim Boreham: Oventus Medical
Health & Biotech
Dr Boreham’s Crucible: PharmAust wants a piece of the +$US10.2b pet drug market
Health & Biotech
Dr Boreham’s Crucible: Imagion gears up for human breast cancer trials, but market value falls way short of peers
Health & Biotech